Dr. Kris Discusses ASCO 2012 Lung Cancer Information

Video

Dr. Mark Kris, from Memorial Sloan-Kettering Cancer Center, Discusses Lung Cancer Information Presented at the 2012 ASCO Annual Meeting.

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses the lung cancer information and data that was presented at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

Kris believes that although multiple studies were presented at the 2012 ASCO Annual Meeting, one single study was not a huge breakthrough. However, he adds that when all of the studies are taken together they represent a very important fundamental change for the care of patients with lung cancer.

The most important advance that was highlighted in the studies was the explosion in the understanding of the molecular basis of lung cancer. This information has helped to further define the prognosis and course of each subtype of lung cancer and may potentially lead to the identification of novel targeted therapies.

While chemotherapy has offered multiple benefits to some patients, most do not benefit or will only benefit for a short time. Because of this, the transition towards targeted therapies has provided tremendous changes and benefits for the treatment of patients with lung cancer.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute